Platelet aggregation in the formation of tumor metastasis

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 84, Issue 6, 2008, Pages 189-198

  Tsuruo, Takashi ^a,b   Fujita, Naoya ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aggrus podoplanin; O glycan; Platelet aggregation; Tumor metastasis

Indexed keywords

HUMAN; METASTASIS; REVIEW; THROMBOCYTE AGGREGATION;

HUMANS; NEOPLASM METASTASIS; PLATELET AGGREGATION;

EID: 45349099160     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.84.189     Document Type: Review

References (57)

1. Klinger, M. H. and Jelkmann, W. (2002) Role of blood platelets in infection and inflammation. J. Interferon Cytokine Res. 22, 913-922.
2. Oleksowicz, L. and Dutcher, J. P. (1995) Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies. Med. Oncol. 12, 95-102.
3. Honn, K. V., Tang, D. G. and Crissman J. D. (1992) Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 11, 325-351.
4. Fidler, I. J. (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458.
5. Crissman, J. D., Hatfield, J. S., Menter, D. G., Sloane, B. and Honn, K. V. (1988) Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res. 48, 4065-4072.
6. Bradley, C. J., Dauer, R. J., Thurlow, P. J. and Connellan, J. M. (1997) Characterization of platelet aggregation induced by the human carcinosarcoma Colo 526: role of platelet activation, tumor cell cytoskeleton and tumor cell plasma membrane. Pathology 29, 189-195.
7. Honn, K. V., Onoda, J. M., Diglio, C. A., Carufel, M. M., Taylor, J. D. and Sloane, B. F. (1984) Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine. Clin. Exp. Metastasis 2, 61-72.
8. Honn, K. V., Onoda, J. M., Pampalona, K., Battaglia, M., Neagos, G., Taylor, J. D., Diglio, C. A. and Sloane, B. F. (1985) Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet- endothelial cell interactions in vitro and metastasis in vivo. Biochem. Pharmacol. 34, 235-241.
9. Tsuruo, T., Iida, H., Makishima, F., Yamori, T., Kawabata, H., Tsukagoshi, S. and Sakurai, Y. (1985) Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil. Cancer Chemother. Pharmacol. 14, 30-33.
10. Corbett, T. H., Griswold, D. P. Jr., Roberts, B. J., Peckham, J. C. and Schabel, F. M. Jr. (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35, 2434-2439.
11. Tsuruo, T., Yamori, T., Naganuma, K., Tsukagoshi, S. and Sakurai, Y. (1983) Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res. 43, 5437-5442.
12. Yamori, T., Tsuruo, T., Naganuma, K., Tsukagoshi, S. and Sakurai, Y. (1984) Isolation and characterization of highly and rarely metastatic clones from murine colon adenocarcinoma. Invasion Metastasis 4, 84-97.
13. Tsuruo, T., Kawabata, H., Iida, H. and Yamori, T. (1986) Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis. Clin. Exp. Metastasis 4, 25-33.
14. Yamori, T., Iida, H., Tsukagoshi, S. and Tsuruo, T. (1988) Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization. Clin. Exp. Metastasis 6, 131-139.
15. Tsuruo, T., Watanabe, M. and Oh-hara, T. (1989) Stimulation of the growth of metastatic clones of mouse colon adenocarcinoma 26 in vitro by platelet-derived growth factor. Jpn. J. Cancer Res. 80, 136-140.
16. Koenuma, M., Yamori, T. and Tsuruo, T. (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn. J. Cancer Res. 80, 51-58.
17. r 160,000 protein in highly metastatic mouse colon carcinoma 26 NL-17 cells. Cancer Res. 51, 5859-5865.
18. Sugimoto, Y., Oh-hara, T., Watanabe, M., Saito, H., Yamori, T. and Tsuruo, T. (1987) Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential. Cancer Res. 47, 4396-4401.
19. r 44,000 membrane protein as determined by monoclonal antibodies. Cancer Res. 48, 6411-6416.
20. r 41,000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma. Cancer Res. 50, 6657-6662.
21. Sugimoto, Y., Watanabe, M., Oh-hara, T., Sato, S., Isoe, T. and Tsuruo, T. (1991) Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res. 51, 921-925.
22. Toyoshima, M., Nakajima, M., Yamori, T. and Tsuruo, T. (1995) Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res. 55, 767-773.
23. Kato, Y., Fujita, N., Kunita, A., Sato, S., Kaneko, M., Osawa, M. and Tsuruo, T. (2003) Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. J. Biol. Chem. 278, 51599-51605.
24. Zhang, Y., Fujita, N., Oh-hara, T., Morinaga, Y., Nakagawa, T., Yamada, M. and Tsuruo, T. (1998) Production of interleukin-11 in bone-derived endothelial cells and its role in the formation of osteolytic bone metastasis. Oncogene 16, 693-703.
25. Nose, K., Saito, H. and Kuroki, T. (1990) Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ. 1, 511-518.
26. Farr, A. G., Berry, M. L., Kim, A., Nelson, A. J., Welch, M. P. and Aruffo, A. (1992) Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J. Exp. Med. 176, 1477-1482.
27. Taniguchi, K., Harada, N., Ohizumi, I., Kinoshita, M., Tsutsumi, Y., Nakagawa, S., Kaiho, S. and Mayumi, T. (2000) Molecular cloning and characterization of antigens expressed on rat tumor vascular endothelial cells. Int. J. Cancer 86, 799-805.
28. Zimmer, G., Lottspeich, F., Maisner, A., Klenk, H. D. and Herrler, G. (1997) Molecular characterization of gp40, a mucin-type glycoprotein from the apical plasma membrane of Madin-Darby canine kidney cells (type I). Biochem. J. 326, 99-108.
29. Zimmer, G., Oeffner, F., Von Messling, V., Tschernig, T., Gröness, H. J., Klenk, H. D. and Herrler, G. (1999) Cloning and characterization of gp36, a human mucin-type glycoprotein preferentially expressed in vascular endothelium. Biochem. J. 341, 277-284.
30. Gandarillas, A., Scholl, F. G., Benito, N., Gamallo, C. and Quintanilla, M. (1997) Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol. Carcinog. 20, 10-18.
31. Kotani, M., Osanai, T., Tajima, Y., Kato, H., Imada, M., Kaneda, H., Kubo, H. and Sakuraba, H. (2002) Identification of neuronal cell lineage-specific molecules in the neuronal differentiation of P19 EC cells and mouse central nervous system. J. Neurosci. Res. 67, 595-606.
32. McElroy, M. C., Pittet, J. F., Hashimoto, S., Allen, L., Wiener-Kronish, J. P. and Dobbs, L. G. (1995) A type I cell-specific protein is a biochemical marker of epithelial injury in a rat model of pneumonia. Am. J. Physiol. 268, L181-L186.
33. Rishi, A. K., Joyce-Brady, M., Fisher, J., Dobbs, L. G., Floros, J., VanderSpek, J., Brody, J. S. and Williams, M. C. (1995) Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev. Biol. 167, 294-306.
34. Wetterwald, A., Hoffstetter, W., Cecchini, M. G., Lanske, B., Wagner, C., Fleisch, H. and Atkinson, M. (1996) Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 18, 125-132.
35. Breiteneder-Geleff, S., Matsui, K., Soleiman, A., Meraner, P., Poczewski, H., Kalt, R., Schaffner, G. and Kerjaschki, D. (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 151, 1141-1152.
36. Schacht, V., Ramirez, M. I., Hong, Y. K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A. M., Dvorak, H. F., Oliver, G. et al. (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556.
37. Ramirez, M. I., Millien, G., Hinds, A., Cao, Y., Seldin, D. C. and Williams, M. C. (2003) T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 256, 61-72.
38. Kaneko, M. K., Kato, Y., Kitano, T. and Osawa, M. (2006) Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor. Gene 378, 52-57.
39. Kunita, A., Kashima, T. G., Morishita, Y., Fukayama, M., Kato, Y., Tsuruo, T. and Fujita, N. (2007) The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis. Am. J. Pathol. 170, 1337-1347.
40. Kaneko, M. K., Kato, Y., Kameyama, A., Ito, H., Kuno, A., Hirabayashi, J., Kubota, T., Amano, K., Chiba, Y., Hasegawa, Y., et al. (2007) Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. FEBS Lett. 581, 331-336.
41. Kaneko, M., Kato, Y., Kunita, A., Fujita, N., Tsuruo, T. and Osawa, M. (2004) Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells. J. Biol. Chem. 279, 38838-38843.
42. Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H. and Ozaki, Y. (2007) Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 282, 25993-26001.
43. Kato, Y., Kaneko, M. K., Kunita, A., Ito, H., Kameyama, A., Ogasawara, S., Matsuura, N., Hasegawa, Y., Suzuki-Inoue, K., Inoue, O., Ozaki, Y. and Narimatsu, H. (2008) Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci. 99, 54-61.
44. Suzuki-Inoue, K., Fuller, G. L., García, A., Eble, J. A., Pöhlmann, S., Inoue, O., Gartner, T. K., Hughan, S. C., Pearce, A. C., Laing, G. D., et al. (2006) A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107, 542-549.
45. Martín-Villar, E., Megías, D., Castel, S., Yurrita, M. M., Vilaró, S. and Quintanilla, M. (2006) Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell. Sci. 119, 4541-4553.
46. Ohizumi, I., Harada, N., Taniguchi, K., Tsutsumi, Y., Nakagawa, S., Kaiho, S. and Mayumi, T. (2000) Association of CD44 with OTS-8 in tumor vascular endothelial cells. Biochim. Biophys. Acta 1497, 197-203.
47. Nakazawa, Y., Sato, S., Naito, M., Kato, Y., Mishima, K., Arai, H., Tsuruo, T. and Fujita, N. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood (in press).
48. Ordonez, N. G. (2006) Podoplanin: a novel diagnostic immunohistochemical marker. Adv. Anat. Pathol. 13, 83-88.
49. Wicki, A. and Christofori, G. (2007) The potential role of podoplanin in tumour invasion. Br. J. Cancer 96, 1-5.
50. Kahn, H. J., Bailey, D. and Marks, A. (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod. Pathol. 15, 434-440.
51. Schacht, V., Dadras, S. S., Johnson, L. A., Jackson, D. G., Hong, Y. K. and Detmar, M. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166, 913-921.
52. Kato, Y., Kaneko, M., Sata, M., Fujita, N., Tsuruo, T. and Osawa, M. (2005) Enhanced expression of Aggrus (T1alpha/Podoplanin), a platelet aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol. 26, 195-200.
53. Mishima, K., Kato, Y., Kaneko, M. K., Nakazawa, Y., Kunita, A., Fujita, N., Tsuruo, T., Nishikawa, R., Hirose, T. and Matsutani, M. (2006) Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma. Acta Neuropathol. 111, 563-568.
54. Mishima, K., Kato, Y., Kaneko, M. K., Nishikawa, R., Hirose, T. and Matsutani, M. (2006) Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol. 111, 483-488.
55. Kimura, N. and Kimura, I. (2005) Podoplanin as a marker for mesothelioma. Pathol. Int. 55, 83-86.
56. Kato, Y., Sasagawa, I., Kaneko, M., Osawa, M., Fujita, N. and Tsuruo, T. (2004) Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors. Oncogene 23, 8552-8556.
57. Morimoto, K., Satoh-Yamaguchi, K., Hamaguchi, A., Inoue, Y., Takeuchi, M., Okada, M., Ikeda, W., Takai, Y. and Imai, T. (2008) Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs. Oncogene 27, 264-273.